FDA Inspection
Abbvie Operations Singapore Pte LtdAbbvie Operations Singapore Pte Ltd – FDA Inspection, Sep 4, 2026
Record Details
This FDA Inspection record concerns Abbvie Operations Singapore Pte Ltd, with an inspection on September 4, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · eba27346-6057-4700-a469-4d883b3ff524
Inspection Facts
- Inspection number
- 1340398
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Abbvie Operations Singapore Pte Ltd
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 21, 2024 | VAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| May 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2018 | Not classified | Office of Inspections and Investigations | |
| March 9, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Abbvie Operations Singapore Pte Ltd
- FDA Inspection 1241925 - 2024-06-21
- FDA Inspection 1092479 - 2019-05-10
- FDA Inspection 1077523 - 2018-12-05
- FDA Inspection 1006415 - 2017-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.